Favorable safety profile of Pradaxa (dabigatran etexilate) confirmed in
Complete Phase II results from the prospective GLORIATM-AF registry in dabig...
2018-03-23
文传商讯
AstraZeneca’s Calquence (acalabrutinib) Shows Potential in Chronic Lym
Data from two Phase I/II trials presented at American Society of Hematology ...
2017-12-13
文传商讯
Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA Shows Posi
Once-daily single tablet complete regimen demonstrates effective viral suppr...
2017-10-27
文传商讯
Safety and efficacy results from the INJOURNEYTM trial investigating OF
Data from this 12-week study show that the safety and tolerability profile o...
2017-09-12
文传商讯
